Results 211 to 220 of about 3,100,016 (354)

Influenza A Virus Production Following Quality by Design Principles. [PDF]

Eng Life Sci
Zinnecker T, Thiele K, Schmidberger T, Genzel Y, Reichl U.   +4 more
europepmc   +1 more source

Antiviral effects and mechanism of Qi pi pill against influenza viruses

Animal Models and Experimental Medicine, EarlyView.
Qi pi pill presents anti‐influenza effect and inhibits viral replication in vitro by targeting both the viral RNA replication and the release of new viral particles. Furthermore, QPP modulates the production of proinflammatory cytokines induced by influenza infection in host cells.
Chengcheng Zhang, Jing Gao, Meiyue Dong, Carolina Q. Sacramento, Ping Li, Xiangyu Lian, Lingyuan Fan, Lijun Rong, Ruikun Du, Jingzhen Tian, Qinghua Cui   +10 more
wiley   +1 more source

Studies on air-borne virus infections: I. Experimental technique and preliminary observations on influenza and infectious ectromelia [PDF]

, 1943
D. G. ff. Edward, W. J. Elford, P. P. Laidlaw   +2 more
openalex   +1 more source

Antiviral Activity of Berbamine Against Influenza A Virus Infection. [PDF]

Int J Mol Sci
Cho WK, Choi HJ, Ma JY.
europepmc   +1 more source

Transplanting neural stem cells overexpressing miRNA‐21 can promote neural recovery after cerebral hemorrhage through the SOX2/LIN28‐let‐7 signaling pathway

Animal Models and Experimental Medicine, EarlyView.
Abstract Background Intracerebral hemorrhage (ICH) remains a devastating neurological disorder with limited therapeutic options. Neural stem cell (NSC)‐based therapies have emerged as a potential regenerative approach, yet the molecular mechanisms regulating NSC behavior require further elucidation.
Wei Dai, Yongxia Li, Jiarui Du, Gang Shen, Meimei Fan, Zuopeng Su, Fulin Xu, Fang Yuan   +7 more
wiley   +1 more source

Importance of Antigenic Composition of Influenza Virus Vaccine in Protecting against the Natural Disease

, 1949
Jonas Salk, Philip C. Suriano
openalex   +1 more source

GROWTH CHARACTERISTICS OF INFLUENZA VIRUS [PDF]

, 1955
W. W. Ackermann, H. F. Maassab
openalex   +1 more source

Catch, Cut, or Block? Versatile 4‐N‐Derivatized Sialyl Glycosides for Influenza Virus Neuraminidase Detection and Purification

Angewandte Chemie, EarlyView.
Sialyl glycosides containing 4‐N‐derivatized sialic acids synthesized by a highly efficient one‐pot two‐enzyme (OP2E) chemoenzymatic sialylation strategy have been shown to be versatile probes. They can resist sialidase cleavage, be selective substrates by influenza sialidases, or be nanomolar substrate analog‐based inhibitors and affinity ligands ...
Yue Yuan, Hai Yu, Anand Kumar Agrahari, Jin Gao, Hyeog Kang, Robert Daniels, Xi Chen   +6 more
wiley   +2 more sources

Circulation and Spillover of pdmH1N1 Influenza A Virus at an Educational Swine Farm in Chile, 2019-2023. [PDF]

Viruses
Ruiz S, Díaz-Gavidia C, González MA, Galdames P, Oyarzún C, Baumberger C, Rojas C, Hamilton-West C, Sharp B, Tan S, Schultz-Cherry S, Jimenez-Bluhm P.   +11 more
europepmc   +1 more source

Respiratory virus mRNA vaccines: mRNA Design, clinical studies, and future challenges

Animal Models and Experimental Medicine, EarlyView.
Abstract Respiratory infectious diseases frequently erupt on a global scale, with RNA viruses, such as SARS‐CoV‐2, RSV, and influenza viruses, posing challenges to vaccine development due to their high mutation rates. Traditional vaccine development cycles are lengthy and struggle to keep pace with rapidly evolving viruses, whereas messenger RNA (mRNA)
Linlin Zheng, Han Feng
wiley   +1 more source